Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK GBp

Target Healthcare REIT PLC (THRLL.XC)

98.05
-1.15
(-1.16%)
At close: 4:23:08 PM GMT+1
Loading Chart for THRLL.XC
  • Previous Close 99.20
  • Open 99.80
  • Bid 98.00 x --
  • Ask 98.50 x --
  • Day's Range 97.90 - 99.90
  • 52 Week Range 75.30 - 99.90
  • Volume 198,963
  • Avg. Volume 0
  • Market Cap (intraday) 620.421M
  • Beta (5Y Monthly) 0.44
  • PE Ratio (TTM) 817.08
  • EPS (TTM) 0.12
  • Earnings Date --
  • Forward Dividend & Yield 0.06 (6.99%)
  • Ex-Dividend Date Feb 13, 2025
  • 1y Target Est --

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 31 December 2023 comprised 98 assets let to 32 tenants with a total value of £911.1 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.

www.targethealthcarereit.co.uk

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: THRLL.XC

View More

Performance Overview: THRLL.XC

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

THRLL.XC
16.47%
FTSE 100 (^FTSE)
3.94%

1-Year Return

THRLL.XC
25.95%
FTSE 100 (^FTSE)
4.31%

3-Year Return

THRLL.XC
11.96%
FTSE 100 (^FTSE)
12.60%

5-Year Return

THRLL.XC
9.25%
FTSE 100 (^FTSE)
43.95%

Compare To: THRLL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: THRLL.XC

View More

Valuation Measures

Annual
As of 2/17/2025
  • Market Cap

    614.66M

  • Enterprise Value

    --

  • Trailing P/E

    7.15

  • Forward P/E

    13.59

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.65

  • Price/Book (mrq)

    0.76

  • Enterprise Value/Revenue

    9.86

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    102.07%

  • Return on Assets (ttm)

    3.83%

  • Return on Equity (ttm)

    10.58%

  • Revenue (ttm)

    70.76M

  • Net Income Avi to Common (ttm)

    72.22M

  • Diluted EPS (ttm)

    0.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.92M

  • Total Debt/Equity (mrq)

    35.12%

  • Levered Free Cash Flow (ttm)

    41.26M

Research Analysis: THRLL.XC

View More

Company Insights: THRLL.XC

Research Reports: THRLL.XC

View More

People Also Watch